Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Faeth Therapeutics, Inc.

NASDAQ: FTH · Life Sciences · 6 alerts · CIK 1829802

Share price
$9.28Close, Nov 16
Market cap
$240M
Shares outstanding
25.84MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Faeth Therapeutics, Inc. filings on SEC EDGAR ↗

8:14 AM ET 8-K
Financial Results

Faeth Therapeutics Financial Results

Faeth Therapeutics reported third quarter 2026 financial results, ending the period with $174.8 million in cash and marketable securities. The company highlighted the receipt of FDA Fast Track designation for its lead program PIKTOR in endometrial cancer and expects topline Phase 2 data by year-end 2026.

Term
Q3 2026

“We designed PIKTOR, an all-oral, multi-node inhibitor, to address those limitations, and we believe it has the potential to give patients a differentiated treatment option. We look forward to reading out topline data from our Phase 2 PIK-201 trial in endometrial cancer by year-end, and to reporting initial safety and efficacy data from our PIK-101 trial in HR+/HER2- breast cancer in 2027.”

Anand Parikh, Chief Executive Officer
8:10 AM ET 10-Q
Financial Results

Faeth Therapeutics Q3 2026 Results: Net Loss of $20.4M, Loss Widens

Faeth Therapeutics reported a significant net loss of $206.6 million for the nine months ended September 30, 2026, primarily driven by a $133.0 million charge for acquired in-process research and development. The company significantly strengthened its balance sheet during the period, ending with $174.8 million in cash and marketable securities following a private placement and acquisition.

Key figure
Net loss $20.4M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.